Volume 23, Number 6—June 2017
Dispatch
Clinical and Molecular Characteristics of Human Rotavirus G8P[8] Outbreak Strain, Japan, 2014
Table 2
Genotype constellations and nucleotide identities of strains closely related to To14-0, the representative G8P[8] rotavirus strain used in a study of the clinical and molecular features of a G8P[8] rotavirus outbreak strain, Hokkaido Prefecture, Japan, 2014
Strain (genotype representative from study/country) | Genotype constellations and nucleotide identities (%), by gene* |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
VP7 | VP4 | VP6 | VP1 | VP2 | VP3 | NSP1 | NSP2 | NSP3 | NSP4 | NSP5 | |
Human/To14-0 (G8P[8] in study) |
G8 (100) |
P[8] (100) |
I2 (100) |
R2 (100) |
C2 (100) |
M2 (100) |
A2 (100) |
N2 (100) |
T2 (100) |
E2 (100) |
H2 (100) |
Human/VNM/RVN1149/2014/G8P[8] (G8P[8] in Vietnam) |
G8 (99.4) |
P[8] (99.8) |
I2 (99.8) |
R2 (99.6) |
C2 (99.6) |
M2 (99.8) |
A2 (100) |
N2 (99.9) |
T2 (99.5) |
E2 (99.9) |
H2 (99.5) |
Human/THA/NP-130/2014/G8P[8] (G8P[8] in Thailand) |
G8 (99.7) |
P[8] (99.9) |
I2 (99.9) |
R2 (99.9) |
C2 (99.8) |
M2 (99.9) |
A2 (99.9) |
N2 (99.7) |
T2 (99.8) |
E2 (99.7) |
H2 (99.5) |
Human/THA/KKL-17/2013/G8P[8] (G8P[8] in Thailand) |
G8 (99.5) |
P[8] (99.8) |
I2 (91.5) |
R2 (99.9) |
C2 (99.9) |
M2 (99.9) |
A2 (99.9) |
N2 (99.8) |
T2 (99.9) |
E2 (99.7) |
H2 (99.2) |
Human/THA/LS-04/2013/G2P[8]
(DS-1–like G2P[8] in Thailand) |
G2
(–) |
P[8] (99.8) |
I2 (99.5) |
R2 (86.0) |
C2 (99.8) |
M2 (97.4) |
A2 (99.9) |
N2 (99.8) |
T2 (98.6) |
E2 (95.5) |
H2 (99.7) |
Human/THA/SKT-109/2013/G1P[8] (DS-1–like G1P[8] in Thailand) |
G1
(–) |
P[8] (99.7) |
I2 (98.7) |
R2 (86.1) |
C2 (99.9) |
M2 (99.8) |
A2 (99.8) |
N2 (85.8) |
T2 (99.8) |
E2 (94.5) |
H2 (99.2) |
Human/To14-41 (DS-1–like G1P[8] in study) |
G1
(–) |
P[8] (98.8) |
I2 (98.3) |
R2 (86.3) |
C2 (99.4) |
M2 (99.4) |
A2 (99.5) |
N2 (85.5) |
T2 (99.6) |
E2 (93.5) |
H2 (98.8) |
Human/JPN/NT004/2012/G1P[8]
(DS-1–like G1P[8] in Japan) |
G1
(–) |
P[8] (99.0) |
I2 (98.4) |
R2 (86.3) |
C2 (99.7) |
M2 (99.5) |
A2 (99.5) |
N2 (85.6) |
T2 (99.6) |
E2 (94.5) |
H2 (99.2) |
Human/THA/NP-M51/2013/G2P[4] (G2P[4] in Thailand) |
G2
(–) |
P[4]
(–) |
I2 (99.5) |
R2 (86.0) |
C2 (99.1) |
M2 (97.5) |
A2 (99.0) |
N2 (85.4) |
T2 (98.7) |
E2 (95.5) |
H2 (99.7) |
Human/KOR/CAU15–11/2015/G2P[4] (G2P[4] in South Korea) |
G2
(–) |
P[4]
(–) |
I2 (99.5) |
R2 (85.9) |
C2 (99.2) |
M2 (97.4) |
A2 (94.0) |
N2 (84.8) |
T2 (98.1) |
E2 (95.3) |
H2 (98.6) |
Human/MU14114 (G2P[4] in study) |
G2
(–) |
P[4]
(–) |
I2 (97.0) |
R2 (85.3) |
C2 (96.9) |
M2 (86.4) |
A2 (95.8) |
N2 (85.5) |
T2 (96.7) |
E2 (95.6) |
H2 (98.3) |
Human/ITA/PR457/2009/G10P[14] |
G10
(–) |
P[14]
(–) |
I2 (93.0) |
R2 (98.1) |
C2 (82.3) |
M2 (86.6) |
A11
(–) |
N2 (86.4) |
T6
(–) |
E2 (94.3) |
H3
(–) |
Caprine/BGL/GO34/1999/G6P[1] |
G6
(–) |
P[1]
(–) |
I2 (94.9) |
R2 (86.3) |
C2 (83.4) |
M2 (86.8) |
A11
(–) |
N2 (86.6) |
T6
(–) |
E2 (96.0) |
H3
(–) |
Human/COD/DRC88/2003/G8P[8] (G8P[8] in Africa) |
G8 (86.0) |
P[8] (98.3) |
I2 (96.3) |
R2 (85.6) |
C2 (97.4) |
M2 (97.0) |
A2 (96.4) |
N2 (85.8) |
T2 (97.1) |
E2 (90.1) |
H2 (97.4) |
Human/MWI/QEC287/2006/G8P[8] (G8P[8] in Africa) |
G8 (85.5) |
P[8] (98.3) |
I2 (96.3) |
R2 (85.6) |
C2 (97.8) |
M2 (96.0) |
A2 (96.5) |
N2 (86.9) |
T2 (96.6) |
E2 (89.2) |
H2 (97.6) |
Human/MWI/QEC289/2006/G8P[8] (G8P[8] in Africa) | G8 (85.5) | P[8] (97.5) | I2 (96.3) | R2 (85.5) | C2 (97.8) | M2 (95.9) | A2 (96.5) | N2 (86.9) | T2 (96.6) | E2 (89.2) | H2 (97.6) |
*Purple indicates G8 genotype; green indicates Wa-like genome segments; red indicates DS-1–like genome segments; bold indicates nucleotide identities >99.0%; – indicates percentages not calculated because the genotype was different that for To14-0.
Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.